Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Molecular Biotechnology|September 19, 2003
Hybrid-cell vaccines for cancer immune therapyUwe Trefzer, Peter WaldenCase Reports in Dermatology|April 8, 2014
Remission of an intracardiac melanoma metastasis after tremelimumab therapySebastian Spethmann, Uwe Trefzer, Fabian KnebelFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 18, 2009
Differential arginine methylation of the G-protein pathway suppressor GPS-2 recognized by tumor-specific T cells in melanomaSaulius Jarmalavicius, Uwe Trefzer, Peter WaldenJapanese Journal of Clinical Oncology|May 3, 2007
Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?Maja A Hofmann, Wolfram Sterry, Uwe TrefzerExpert Opinion on Biological Therapy|July 26, 2003
Cytokine and anticytokine therapy in dermatologyUwe Trefzer, Maja Hofmann, Wolfram Sterry, et al.Plos One|April 22, 2009
Proteome serological determination of tumor-associated antigens in melanomaMichael Forgber, Uwe Trefzer, Wolfram Sterry, et al.Anticancer Research|May 18, 2012
Vaginal fistula in a patient with relapsed ovarian cancer and amelanotic melanomaMustafa Zelal Muallem, Sule Yildiz, Ruza Arsenic, et al.Journal of Cancer Research and Clinical Oncology|May 11, 2010
Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanomaMaja A Hofmann, Felix Kiecker, Ingeborg Küchler, et al.Cancer Research|May 19, 2005
Expression of human endogenous retrovirus K in melanomas and melanoma cell linesKristina Büscher, Uwe Trefzer, Maja Hofmann, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 7, 2007
Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approachesJürgen Eberle, Bahtier M Kurbanov, Amir M Hossini, et al.Pageof 7